| HGNC Family | Non-coding RNAs |
| Name | microRNA 628 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐628, encompassing both the miR‐628‐3p and miR‐628‐5p isoforms, has emerged as a multifunctional regulator in diverse pathological settings. In viral infection, an altered expression of miR‐628‐3p was identified as part of a fourteen‐member dysregulated microRNA signature in H1N1 influenza patients and infected cells, suggesting that it may contribute to host antiviral responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In renal cell carcinoma, miR‐628‐5p has been implicated in the post‐transcriptional repression of HLA‐G, a non‐classical major histocompatibility complex molecule involved in inhibiting NK cell cytotoxicity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In the arena of diagnostic biomarkers, circulating levels of miR‐628‐5p are diminished in the serum of prostate cancer patients"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", while its selective enrichment in salivary small extracellular vesicles has shown promising discriminatory power for periodontitis diagnosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer settings, miR‐628‐5p often acts as a tumor suppressor through targeting key oncogenic drivers. In ovarian cancer, for example, miR‐628‐5p decreases the stem‐like cell population by inducing apoptosis via down‐regulation of fibroblast growth factor receptor 2."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Consistent with this role, in lung cancer miR‐628‐3p has been shown to promote apoptosis and inhibit cellular migration by repressing heat shock protein 90a."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Similarly, in glioma, forced expression of miR‐628‐5p reduces proliferation and induces G1 cell cycle arrest by targeting DDX59"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while in gastric cancer a circRNA competitively sponging miR‐628‐5p leads to higher NT5E levels; hence, miR‐628‐5p normally constrains tumorigenesis by inhibiting NT5E expression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " In pancreatic ductal adenocarcinoma, reduced miR‐628‐5p expression correlates with worse survival, with mechanistic insights implicating its suppression of phospholipid scramblase 1 and insulin receptor substrate 1, thereby inhibiting the downstream AKT/NF‐κB signaling pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " Moreover, in glioblastoma, a recently described circ_HN1/miR‐628‐5p/HMGB3 regulatory axis appears to influence tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, data from osteosarcoma studies indicate that miR‐628‐5p might exert an oncogenic role by promoting cell proliferation, migration, and invasion via suppression of interferon‐induced protein 44‐like (IFI44L)."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Beyond oncogenesis, miR‐628‐3p has been shown to attenuate osteoblast differentiation by directly targeting the master transcription factor RUNX2, linking its dysregulation to the pathogenesis of atrophic non‐union."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Emerging data also point to a potential role in inflammatory conditions; for instance, although the contribution of miR‐628‐5p in cervical cancer remains to be fully elucidated"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", plasma levels of miR‐628‐3p have been associated with the severity of ocular inflammation in patients with atopic dermatitis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Collectively, these studies underscore that the function of miR‐628 is highly context‐dependent—it may act either as a tumor suppressor or as an oncomiR and serves as a promising candidate biomarker in both infectious and non‐infectious diseases.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Paul A Tambyah, Sugunavathi Sepramaniam, Jaminah Mohamed Ali, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNAs in circulation are altered in response to influenza A virus infection in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0076811"}], "href": "https://doi.org/10.1371/journal.pone.0076811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24116168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24116168"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Simon Jasinski-Bergner, Adi Reches, Christine Stoehr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8567"}], "href": "https://doi.org/10.18632/oncotarget.8567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27057628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27057628"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Anvesha Srivastava, Helle Goldberger, Alexander Dimtchev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulatory miR-628-5p is downregulated in prostate cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-1638-1"}], "href": "https://doi.org/10.1007/s13277-014-1638-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24477576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24477576"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xu Zhao, Yajun Liu, Chenggong Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AGAP2-AS1/miR-628-5p/FOXP2 feedback loop facilitates the growth of prostate cancer via activating WNT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgab062"}], "href": "https://doi.org/10.1093/carcin/bgab062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34255057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34255057"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Pingping Han, Peter Mark Bartold, Carlos Salomon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salivary Small Extracellular Vesicles Associated miRNAs in Periodontal Status-A Pilot Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21082809"}], "href": "https://doi.org/10.3390/ijms21082809"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32316600"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32316600"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ming Li, Zhimin Qian, Xiaoling Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-628-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at FGFR2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.12.049"}], "href": "https://doi.org/10.1016/j.bbrc.2017.12.049"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29229394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29229394"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jieli Pan, Fusheng Jiang, Jia Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HSP90: A Novel Target Gene of miRNA-628-3p in A549 Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2018/4149707"}], "href": "https://doi.org/10.1155/2018/4149707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29888262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29888262"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Peng Xie, Yan Wang, Yuanmei Liao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-628-5p inhibits cell proliferation in glioma by targeting DDX59."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28991"}], "href": "https://doi.org/10.1002/jcb.28991"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31111544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31111544"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yang Chen, Yaran Wu, Shuhui Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiency of microRNA-628-5p promotes the progression of gastric cancer by upregulating PIN1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-02766-6"}], "href": "https://doi.org/10.1038/s41419-020-02766-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32703934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32703934"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Lin Zhou, Xiaoxiao Jiao, Xiaoqian Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29468"}], "href": "https://doi.org/10.1002/jcp.29468"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31957029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31957029"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "W-L Chen, L Jiang, J-S Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201912_19791"}], "href": "https://doi.org/10.26355/eurrev_201912_19791"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31858556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31858556"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ju-Yong Wang, Ju-Qiang Wang, Shi-Bao Lu "}, {"type": "b", "children": [{"type": "t", "text": "miR-628-5p promotes growth and migration of osteosarcoma by targeting IFI44L."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Cell Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1139/bcb-2019-0001"}], "href": "https://doi.org/10.1139/bcb-2019-0001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31018104"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31018104"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Hua Chen, Xinran Ji, Fei She, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-628-3p regulates osteoblast differentiation by targeting RUNX2: Possible role in atrophic non-union."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2016.2839"}], "href": "https://doi.org/10.3892/ijmm.2016.2839"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28035362"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28035362"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Xiaoyan Wu, Jianzhen Lei, Bing Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-628-5p Inhibits Cervical Carcinoma Proliferation and Promotes Apoptosis by Targeting VEGF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.amjms.2020.11.031"}], "href": "https://doi.org/10.1016/j.amjms.2020.11.031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33775424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33775424"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mayumi Ueta, Hiromi Nishigaki, Seitaro Komai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immun Inflamm Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iid3.536"}], "href": "https://doi.org/10.1002/iid3.536"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34547828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34547828"}]}]}]}
|
| Synonyms | MIRN628, HSA-MIR-628, MIR-628 |
| NCBI Gene ID | 693213 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR628 has 300 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 14 datasets.
Click the + buttons to view associations for MIR628 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR628 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR628 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR628 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR628 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR628 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR628 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR628 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR628 from the GeneSigDB Published Gene Signatures dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR628 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR628 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR628 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR628 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR628 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR628 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |